Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

38.80
BATS BZX Real-Time Price
As of 10:18am ET
 +0.12 / +0.31%
Today’s Change
36.00
Today|||52-Week Range
51.74
-13.60%
Year-to-Date
Novo Nordisk IDegLira Recommended by FDA Advisory Committee
May 25 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Resorts to Layoffs for Firdapse Development
May 18 / Zacks.com - Paid Partner Content
Novartis Filing for MabThera Biosimilar Accepted in the EU
May 24 / Zacks.com - Paid Partner Content
Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View
May 17 / Zacks.com - Paid Partner Content
Exelixis' Kidney Cancer Drug Cabometyx Positive in Phase II
May 24 / Zacks.com - Paid Partner Content
Novartis (NVS) Releases Positive Data on Ultibro Breezhaler
May 16 / Zacks.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Mylan to Buy Renaissance's Topical Business for about $1B
May 16 / Zacks.com - Paid Partner Content
Merrimack/Baxalta Start Study on Colorectal Cancer Drug
May 20 / Zacks.com - Paid Partner Content
Drug Stocks Reporting Earnings on May 17: AXON & FWP
May 16 / Zacks.com - Paid Partner Content
Why Noble Energy, Grace, Boston Scientific Belong in Your Portfolio
May 20 / TheStreet.com - Paid Partner Content
Aegerion Enters into Settlement Agreement with DoJ and SEC
May 13 / Zacks.com - Paid Partner Content
These 3 Dividend Stocks Are Down Big -- but Do Their Charts Say Buy?
May 20 / TheStreet.com - Paid Partner Content
Quintiles and IMS jump on the M&A bandwagon
May 04 / FT.com - Paid Partner Content
Roche Gets Accelerated Approval for Immunotherapy Drug
May 19 / Zacks.com - Paid Partner Content
M&A: back with a bang
Apr 29 / FT.com - Paid Partner Content
Should You Buy These 6 Oversold Stocks? The Charts Say No
May 19 / TheStreet.com - Paid Partner Content
Xilinx slides on downbeat sales outlook
Apr 28 / FT.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Three pharma deals worth $45bn reignite M&A boom
Apr 28 / FT.com - Paid Partner Content
Bear of the Day: AbbVie (ABBV)
May 18 / Zacks.com - Paid Partner Content
Abbott to buy St Jude in $25bn deal
Apr 28 / FT.com - Paid Partner Content